<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02087267</url>
  </required_header>
  <id_info>
    <org_study_id>SITONA_01/2014</org_study_id>
    <nct_id>NCT02087267</nct_id>
  </id_info>
  <brief_title>Lumbar Fusion With The Icotec CF/PEEK Pedicle System In Combination With The Icotec CF/PEEK TLIF Cage ETurn™</brief_title>
  <official_title>Lumbar Fusion With The Icotec CF/PEEK Pedicle System In Combination With The Icotec CF/PEEK TLIF Cage ETurn™</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sitona AG</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sitona AG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the PMCF is to collect outcome information on patients suffering from&#xD;
      symptomatic degenerative disc disease or degenerative spondylolisthesis requiring 1- or&#xD;
      2-level lumbar or lumbar-sacral spinal fusion with posterior instrumentation and therefore&#xD;
      receiving the icotec CF/PEEK Pedicle System in combination with the icotec CF/PEEK TLIF Cage&#xD;
      ETurn™.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: At present, metal pedicle screw systems made from titanium or stainless steel are&#xD;
      commonly used for posterior stabilization. One disadvantage of theses metal devices is that&#xD;
      they cause shadows and artifacts on CTs and MRIs which may hamper the postoperative&#xD;
      exploration of the onset of spinal diseases and in particular the evaluation of the&#xD;
      neuroforamina, the spinal canal and bone-implant interfaces. Therefore new concepts of&#xD;
      pedicle screw devices use non-radiopaque materials such as carbon fiber-reinforced&#xD;
      polyetheretherketone (CF/PEEK) without compromising mechanical properties compared to&#xD;
      standard titanium implants and possibly reducing the risk for adjacent segment diseases.&#xD;
&#xD;
      Description of the study devices:&#xD;
&#xD;
      The icotec Pedicle System is intended to provide immobilization and stabilization of spinal&#xD;
      segments in skeletally mature patients as an adjunct to fusion in the treatment of acute and&#xD;
      chronic instabilities or deformities of the thoracic, lumbar and sacral spine. The carbon&#xD;
      fiber-reinforced polyetheretherketone (CF/PEEK) that is used to produce the icotec pedicle&#xD;
      system rod and screw shaft is a thermoplastic composite biomaterial exhibiting properties&#xD;
      suitable for load-bearing orthopedic implants. The CF/PEEK material does not cause artifacts&#xD;
      or shadows on adjacent tissues with all imaging modalities such as x-ray, CT, and MRI.&#xD;
      Radiopaque markers or fibres made from titanium or tantalum are embedded. The pedicle system&#xD;
      rod and screws allow this advantage to be realized without compromising mechanical properties&#xD;
      compared to standard titanium implants.&#xD;
&#xD;
      Description of the study device - icotec CF/PEEK TLIF Cage ETurn: The icotec ETurn™ TLIF cage&#xD;
      consists of a windowed body with a central slot, a distraction/ insertion wedge and surface&#xD;
      treads on its cranial and caudal surfaces that serve to guide and anchor the implant (see&#xD;
      figure 4). The concentrically arranged treads enable the implant to turn on its own from its&#xD;
      position of insertion into the disc space to its transverse end position. The tread surfaces&#xD;
      help to create a significantly larger pressure-bearing contact surface between the implant&#xD;
      and the bone than the conventional pointed anchoring elements.&#xD;
&#xD;
      Risk Analysis and risk Management: Most of the risks of implant related, surgical and&#xD;
      postoperative complications associated with the implantation of the icotec CF/PEEK Pedicle&#xD;
      System in combination with the icotec ETurn™ TLIF cage, are comparable to the risks&#xD;
      associated with other TLIF surgeries with cages and pedicle screw systems intended for lumbar&#xD;
      spine stabilization.&#xD;
&#xD;
      risks and possible adverse outcomes have been identified for the icotec CF/PEEK Pedicle&#xD;
      System as well as for the CF/PEEK TLIF Cage ETurn.&#xD;
&#xD;
      Legal Aspects: For this post-market investigation only CE-marked medical devices will be used&#xD;
      within their intended purpose and no additional invasive or other stressful examinations are&#xD;
      to be carried out.&#xD;
&#xD;
      All subjects will voluntarily sign the Informed Consent document. Ethics approval for the&#xD;
      study will be obtained prior to starting the study&#xD;
&#xD;
      Data Monitoring: Independent on-site Monitoring will be performed at all investigational&#xD;
      sites.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 2014</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Overall fusion rate</measure>
    <time_frame>2 years postoperatively</time_frame>
    <description>Outcome Measure by CT/MRI and clinical follow-up</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of pedicle system implant failures</measure>
    <time_frame>2 years postoperatively</time_frame>
    <description>Outcome Measure by CT/MRI and clinical follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of implant related, surgery related, postoperative and general complications</measure>
    <time_frame>2 years postoperatively</time_frame>
    <description>Outcome Measure by CT/MRI and clinical follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of subsequent surgical interventions</measure>
    <time_frame>2 years postoperatively</time_frame>
    <description>Outcome Measure by CT/MRI and clinical follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of the mean total Oswestry Low Back Pain Disability Questionnaire (ODI)</measure>
    <time_frame>Change from the preoperative baseline to the 2 year postoperative assessment</time_frame>
    <description>clinical follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of the mean Visual Analogue Scale (VAS) on low back pain</measure>
    <time_frame>Change from the preoperative baseline to the 2 year postoperative assessment</time_frame>
    <description>clinical follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of the mean Visual Analogue Scale (VAS) on pain in the leg and buttock (experienced in the pain-dominant leg)</measure>
    <time_frame>Change from the preoperative baseline to the 2 year postoperative assessment</time_frame>
    <description>clinical follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analogue Scale (VAS) on patient's satisfaction with the surgery</measure>
    <time_frame>2 years postoperatively</time_frame>
    <description>clinical follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of the mean disc height at index level</measure>
    <time_frame>Change from the preoperative baseline to the 2 year postoperative assessment</time_frame>
    <description>Outcome Measure by CT/MRI and clinical follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of symptomatic adjacent segment disease</measure>
    <time_frame>2 years postoperatively</time_frame>
    <description>Outcome Measure by CT/MRI and clinical follow-up</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">94</enrollment>
  <condition>Degeneration of Lumbar Intervertebral Disc</condition>
  <condition>Degenerative Spondylolisthesis</condition>
  <arm_group>
    <arm_group_label>1- or 2-level spinal fusion</arm_group_label>
    <description>Patients suffering from symptomatic degenerative disc disease or degenerative spondylolisthesis grade 1 or 2 with chronic low back pain, pain in the leg or buttock, muscle weakness, sensation abnormalities and/or neurogenic claudication requiring 1- or 2-level lumbar or lumbar-sacral spinal fusion.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>1- or 2-level spinal fusion</intervention_name>
    <description>1- or 2-level lumbar or lumbar-sacral spinal fusion with the icotec CF/PEEK Pedicle System in combination with the icotec CF/PEEK TLIF Cage ETurn™</description>
    <arm_group_label>1- or 2-level spinal fusion</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Primary care clinic of selected spine centers&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Symptomatic degenerative disc disease or degenerative spondylolisthesis grade 1 or 2&#xD;
             with chronic low back pain, pain in the leg or buttock, muscle weakness, sensation&#xD;
             abnormalities and/or neurogenic claudication&#xD;
&#xD;
          -  Unsuccessful adequate conservative treatment&#xD;
&#xD;
          -  1- or 2- contiguous level lumbar spinal fusion between L2 and S1 with posterior&#xD;
             instrumentation in combination with Transforaminal Lumbar Interbody Fusion (TLIF)&#xD;
&#xD;
          -  Age between 18 - 80 years at the time of surgery&#xD;
&#xD;
          -  Skeletally mature patient&#xD;
&#xD;
          -  Patient understands the conditions of the study and is willing and able to comply with&#xD;
             the postoperative scheduled clinical and imaging evaluations and the prescribed&#xD;
             rehabilitation&#xD;
&#xD;
          -  Patient signed Informed Consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  No adequate non-operative care prior to being treated with a lumbar fusion device&#xD;
&#xD;
          -  3-level fusion or more&#xD;
&#xD;
          -  Fusion not between L2 and S1&#xD;
&#xD;
          -  Previous lumbar spinal surgery, other than discectomy at the level(s) to be operated&#xD;
             on&#xD;
&#xD;
          -  Spondylolisthesis acc. to Meyerding grade 3 or higher&#xD;
&#xD;
          -  Transforaminal access to the disc space is obstructed&#xD;
&#xD;
          -  Use of bone grafts other than autologous grafts, demineralized bone matrix without&#xD;
             additional growth factors and synthetic bone substitute without additional growth&#xD;
             factors. Growth factor enhanced grafts, cement or any other graft material are&#xD;
             excluded.&#xD;
&#xD;
          -  Adiposity, severe obesity (BMI &gt; 35 kg/m2)&#xD;
&#xD;
          -  Any contraindication for MRI scan including heart pacemaker, metallic foreign body&#xD;
             (metal sliver) in the eye or brain, aneurysm clip in the brain, severe claustrophobia&#xD;
             etc.&#xD;
&#xD;
          -  Discitis, spondylodiscitis&#xD;
&#xD;
          -  Acute or chronic infection, previous surgical site infection or severe defect of the&#xD;
             osseous structures&#xD;
&#xD;
          -  Open wounds&#xD;
&#xD;
          -  Patient who takes immunosuppressive or long-term steroid use&#xD;
&#xD;
          -  Fever&#xD;
&#xD;
          -  Allergy or intolerance to any device material (e.g. Carbon/PEEK, titanium or tantalum)&#xD;
&#xD;
          -  Foreign body sensitivity&#xD;
&#xD;
          -  Insufficient form fit between the implant and the bone owing to deformation or&#xD;
             destruction of the pedicles or of the vertebral body end plates&#xD;
&#xD;
          -  Risk that the intervertebral device can subside into the vertebral bodies&#xD;
&#xD;
          -  Bone tumors in the region of the implant anchoring&#xD;
&#xD;
          -  Severe osteoporosis or similar bone density loss, incl. any metabolic bone disease&#xD;
&#xD;
          -  Cases, in which the progression of degenerative disease is so advanced at the time of&#xD;
             implantation that it may substantially decrease the expected useful life of the&#xD;
             appliance&#xD;
&#xD;
          -  Systemic or metabolic illnesses (i.e. insulin-dependent diabetes)&#xD;
&#xD;
          -  Patient who is suffering from rheumatological or other inflammatory joint disease&#xD;
&#xD;
          -  Paralysis of lower extremity&#xD;
&#xD;
          -  Generally poor condition of the patient&#xD;
&#xD;
          -  Psychosocial issues; lack of co-operation by the patient&#xD;
&#xD;
          -  Drug abuse or alcoholism&#xD;
&#xD;
          -  Any medical or surgical condition that could preclude the potential success of the&#xD;
             implantation&#xD;
&#xD;
          -  Any condition not described in the indications for use&#xD;
&#xD;
          -  Unwillingness or inability of the patient to follow the instructions for postoperative&#xD;
             treatment or with the follow-up evaluation schedule&#xD;
&#xD;
          -  Female patient who is pregnant or plans to become pregnant during the course of the&#xD;
             study&#xD;
&#xD;
          -  Prisoner&#xD;
&#xD;
          -  Patient who has not signed the Informed Consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marcus Eif, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Städtisches Klinikum Görlitz gGmbH</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universitätsklinikum SH Klinik für Neurochirurgie</name>
      <address>
        <city>Kiel</city>
        <state>Schleswig-Holstein</state>
        <zip>24105</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Orthopädische Universitätsklinik Friedrichsheim gGmbH</name>
      <address>
        <city>Frankfurt am Main</city>
        <zip>60528</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Städtisches Klinikum Görlitz gGmbH, Klinik für Neurochirurgie</name>
      <address>
        <city>Görlitz</city>
        <zip>02828</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>DIAKOVERE Annastift - Orthopädische Klinik der MHH</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Katholisches Klinikum, Brüderhaus Koblenz</name>
      <address>
        <city>Koblenz</city>
        <zip>56073</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kantonsspital St. Gallen Klinik für Orthopädische Chirurgie und Traumatologie des Bewegungsapparates</name>
      <address>
        <city>St. Gallen</city>
        <zip>9007</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>March 12, 2014</study_first_submitted>
  <study_first_submitted_qc>March 12, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 14, 2014</study_first_posted>
  <last_update_submitted>September 21, 2021</last_update_submitted>
  <last_update_submitted_qc>September 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spondylolisthesis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>will be decided in due time</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

